A Replicative In Vitro Assay for Drug Discovery against Leishmania donovani
about
Unravelling the rate of action of hits in the Leishmania donovani box using standard drugs amphotericin B and miltefosineSnapshot Profiling of the Antileishmanial Potency of Lead Compounds and Drug Candidates against Intracellular Leishmania donovani Amastigotes, with a Focus on Human-Derived Host Cells.Leishmania and other intracellular pathogens: selectivity, drug distribution and PK-PD.In vitro 'time-to-kill' assay to assess the cidal activity dynamics of current reference drugs against Leishmania donovani and Leishmania infantum.Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasisImportance of secondary screening with clinical isolates for anti-leishmania drug discovery
P2860
A Replicative In Vitro Assay for Drug Discovery against Leishmania donovani
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A Replicative In Vitro Assay for Drug Discovery against Leishmania donovani
@en
type
label
A Replicative In Vitro Assay for Drug Discovery against Leishmania donovani
@en
prefLabel
A Replicative In Vitro Assay for Drug Discovery against Leishmania donovani
@en
P2093
P2860
P356
P1476
A Replicative In Vitro Assay for Drug Discovery against Leishmania donovani
@en
P2093
Diana Tegazzini
Fernando Aguilar
Imanol Peña
Jesús L Presa
Jose M Coteron
Juan Cantizani
Julio J Martin
Rosario Díaz
Simon L Croft
Vanessa Yardley
P2860
P304
P356
10.1128/AAC.01781-15
P407
P577
2016-03-28T00:00:00Z